Literature DB >> 28603231

Identification of Aspergillus sections Flavi, Nigri, and Fumigati and their differentiation using specific primers.

Nafiseh Mohebbi Ashtiani1, Reza Kachuei2, Roozbeh Yalfani3, Asghar Beigi Harchegani4, Mohsen Nosratabadi5.   

Abstract

Aspergillus species are important in medicine, agriculture and various industries. The sections Fumigati, Flavi, and Nigri are the most important members of the Aspergillus genus. This study intended to identify and separate these three Aspergillus sections and to differentiate among them using specific primers. A bioinformatics study was initially performed to analyse the sequences of five genes, namely, beta-tubulin, calmodulin, the pre-rRNA processing protein Tsr1, the DNA-replication licensing factor Mcm7, and RNA polymerase II second largest subunit (RPB2) in the three Aspergillus sections using MEGA6 software and the NCBI database. Primers were designed to select genes for each of the Aspergillus sections being analysed. A total of 134 environmental and clinical Aspergillus species were isolated, purified and initially identified by colony morphology.. Subsequently, DNA was extracted using the phenol-chloroform method, specific primers were synthesized, PCR was performed for DNA from all isolates, and the results were compared to morphological characteristics. Of the 134 isolates tested, 56 were Nigri, 32 were Fumigati, 32 were Flavi, and the rest (14 isolates) belonged to other sections. The beta-tubulin and calmodulin genes were found to be the most suitable for differentiating among these three groups; the beta-tubulin gene was used for molecular identification of Aspergillus section Fumigati, and the calmodulin gene for identifying sections Flavi and Nigri.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28603231

Source DB:  PubMed          Journal:  Infez Med        ISSN: 1124-9390


  6 in total

1.  Targeting novel genes for simultaneous detection of five fungal and bacterial agents from BAL samples using multiplex PCR assay.

Authors:  Reza Kamali Kakhki; Mohammad Javad Najafzadeh; Reza Kachuei; Kiarash Ghazvini
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-04-06       Impact factor: 3.267

2.  Morpho-biochemical and molecular characterization of two new strains of Aspergillus fumigatus nHF-01 and A. fumigatus PPR-01 producing broad-spectrum antimicrobial compounds.

Authors:  Vivekananda Mandal; Rajsekhar Adhikary; Pulak Kumar Maiti; Sukhendu Mandal; Vivekananda Mandal
Journal:  Braz J Microbiol       Date:  2021-03-14       Impact factor: 2.476

3.  Unravelling the Molecular Identification and Antifungal Susceptibility Profiles of Aspergillus spp. Isolated from Chronic Pulmonary Aspergillosis Patients in Jakarta, Indonesia: The Emergence of Cryptic Species.

Authors:  Anna Rozaliyani; Asriyani Abdullah; Findra Setianingrum; Wellyzar Sjamsuridzal; Retno Wahyuningsih; Anom Bowolaksono; Ayu Eka Fatril; Robiatul Adawiyah; Mulyati Tugiran; Ridhawati Syam; Heri Wibowo; Chris Kosmidis; David W Denning
Journal:  J Fungi (Basel)       Date:  2022-04-16

4.  Characterization and phylogeny of fungi isolated from industrial wastewater using multiple genes.

Authors:  Blessing Amaka Ezeonuegbu; Machido Dauda Abdullahi; Clement M Z Whong; Japhet Wisdom Sohunago; Hazem S Kassem; Clement Ameh Yaro; Helal F Hetta; Gomaa Mostafa-Hedeab; George D Zouganelis; Gaber El-Saber Batiha
Journal:  Sci Rep       Date:  2022-02-08       Impact factor: 4.379

5.  Assessment of the Microbiome and Potential Aflatoxin Associated With the Medicinal Herb Platycladus orientalis.

Authors:  Jingsheng Yu; Mengyue Guo; Wenjun Jiang; Meihua Yang; Xiaohui Pang
Journal:  Front Microbiol       Date:  2020-10-23       Impact factor: 5.640

6.  In Vitro Activity of Ibrexafungerp against a Collection of Clinical Isolates of Aspergillus, Including Cryptic Species and Cyp51A Mutants, Using EUCAST and CLSI Methodologies.

Authors:  Olga Rivero-Menendez; Juan Carlos Soto-Debran; Manuel Cuenca-Estrella; Ana Alastruey-Izquierdo
Journal:  J Fungi (Basel)       Date:  2021-03-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.